Similar articles

• ORAL CONTRACEPTIVES AND LIVER DAMAGE.

  STOLL BA, ANDREWS JT, MOTTERAM R, UPFILL J. STOLL BA, et al. Br Med J. 1965 Mar 13;1(5436):723. doi: 10.1136/bmj.1.5436.723-a. Br Med J. 1965. PMID: 14245215 Free PMC article. No abstract available.
• JAUNDICE DURING TREATMENT WITH AN ORAL CONTRACEPTIVE, LYNDIOL.

  CULLBERG G, LUNDSTROEM R, STENRAM U. CULLBERG G, et al. Br Med J. 1965 Mar 13;1(5436):695-7. doi: 10.1136/bmj.1.5436.695. Br Med J. 1965. PMID: 14245208 Free PMC article. No abstract available.
• ABSENCE OF HEPATIC IMPAIRMENT IN LONG-TERM ORAL-CONTRACEPTIVE USERS.

  SWYER GI, LITTLE V. SWYER GI, et al. Br Med J. 1965 May 29;1(5447):1412-4. doi: 10.1136/bmj.1.5447.1412. Br Med J. 1965. PMID: 14287002 Free PMC article. No abstract available.
• Comparative metabolism of 17alpha-ethynyl steroids used in oral contraceptives.

  Ranney RE. Ranney RE. J Toxicol Environ Health. 1977 Sep;3(1-2):139-66. doi: 10.1080/15287397709529555. J Toxicol Environ Health. 1977. PMID: 411940 Review.
• HEPATIC CELL INJURY.

  REES KR, SHOTLANDER VL. REES KR, et al. Biochem Clin. 1964;4:181-8. Biochem Clin. 1964. PMID: 14271080 Review. No abstract available.